Clinical Trial Update: The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM) [NA]

View source ↗

Summary

The SQUID Trial evaluated embolization of the middle meningeal artery to treat chronic subdural hematoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Snippet

Sponsor: Balt USA | Conditions: Subdural Hematoma, Chronic | NA | Status: COMPLETED